VLS Vita Life Sciences Limited

ASX · AU · Healthcare · Drug Manufacturers - General · vitalifesciences.com

—Mkt Cap: —P/E: —1d ago

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The comp…

Key Statistics

Company

Market Cap—

Enterprise Value90.73M USD

Revenue (TTM)66.37M USD

Gross Profit39.42M USD

Net Income (TTM)7.21M USD

Revenue/Share1.74 AUD

Last Price—

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees—

CountryAU

SectorHealthcare

IndustryDrug Manufacturers - General

ISINAU000000VLS8

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA8.28

EV/Revenue1.37

P/S1.62

P/B2.92

EPS (TTM)0.20

EPS (Forward)—

52W Range

—

52W High—

52W Low—

Profitability

Gross Margin61.15%

Oper. Margin15.81%

EBITDA Margin16.52%

Profit Margin11.19%

ROE18.55%

ROA12.67%

Growth

Revenue Growth6.10%

Earnings Growth16.70%

Cash Flow & Leverage

Operating CF10.22M USD

CapEx (TTM)393.92K USD

FCF Margin13.01%

FCF Yield—

Net Debt-21.80M USD

Net Debt/EBITDA-1.99

Balance Sheet

Debt/Equity0.04

Current Ratio2.82

Quick Ratio2.10

Book Value/Sh0.99 AUD

Cash/Share0.60 AUD

Dividends

Fwd Div Rate—

Trail. Div Rate0.14 AUD

Div. Yield5.02%

5Y Avg Yield3.89%

Payout Ratio71.60%

Ex-Div DateSep 18, 2026

Pay Date—

Splits

Last Split1:1

Split DateJul 1, 2009

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.53.90M

Float20.06M

Insiders76.91%

Institutions5.47%

Technical

SMA 502.730 AUD

SMA 2002.583 AUD

Beta0.53

S&P 52W Chg16.44%

Avg Vol (30d)—

Avg Vol (10d)9.55K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—

VLS Vita Life Sciences Limited

Industry Peers

Key Statistics